Kesios, a spin-out from Imperial College London, was developing a novel oncology therapeutic for multiple myeloma. Kesios could not replicate the pre-clinical assays of the inventor and the company suspended further development work.
Location: United Kingdom, England, London
Total raised: $28.401362M
Investors 1
| Date | Name | Website |
| - | Abingworth... | abingworth... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.12.2015 | Series A | $28.401362... | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 02.12.2015 | Kesios The... | Kesios Therapeutics Ltd, a Lon... | UK | - | finsmes.co... |
| 08.10.2014 | Kesios The... | Kesios Therapeutics, a London,... | UK | - | finsmes.co... |